Stark Law

FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulgent Genetics, Inc. (NASDAQ: FLGT)

Retrieved on: 
Tuesday, November 1, 2022
Company, Health, Central District, Disclosure, Securities Exchange Act of 1934, Genetics, District court, News, SEC, Battle of Saint-Fulgent, GLOBE, Anti-Kickback Statute, COVID-19, Physician, The Legal 500, Court, Labour government, Stark, Justice, NEW, Investment, NASDAQ, Genetic testing, Reward, U.S. Department of Justice Office of Legislative Affairs, Office of Inspector General, U.S. Department of Health and Human Services, Medicare, Remuneration, Patient, Advertising, Stark Law, Tobacco, Pharmaceutical industry, Security (finance)

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.
  • If you purchased Fulgent securities, and/or would like to discuss your legal rights and options please visit Fulgent Genetics, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, November 1, 2022
IPO, Law, SEC, Battle of Saint-Fulgent, People's Law Office, GLOBE, Time, Anti-Kickback Statute, Barclays, Suite, Telephone, Investment, Company, Remuneration, Class, Stark Law, Defendant, Security (finance), Public relations

BENSALEM, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, November 1, 2022
Health, Growth, Federal, Disclosure, Annual report, BCS, War, PLTR, IPO, Mission statement, News, ADR Institute of Alberta, SEC, Battle of Saint-Fulgent, Intelligence, GLOBE, NYSE, Prospectus, Anti-Kickback Statute, COVID-19, Federation, Physician, Stark Law, Q2, Government, Complaint, Justice, ADS, Sale, Investment, NASDAQ, Genetic testing, Reward, U.S. Department of Defense Strategy for Operating in Cyberspace, U.S. Department of Justice Office of Legislative Affairs, Company, Medicare, EPS, Remuneration, Patient, U.S. Securities and Exchange Commission, ADR, YSG, Security (finance), Animal, Pharmaceutical industry, Audit, Barclays, P.C, Palantir Technologies

The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.

Key Points: 
  • The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.
  • On May 9, 2022, Palantir issued a press release announcing its Q1 financial results and guidance for Q2.
  • For more information on the Barclays class action go to: https://bespc.com/cases/BCS
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

PLTR, FLGT & WBD Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate

Retrieved on: 
Tuesday, November 1, 2022
Security (finance), Growth, U.S. Securities and Exchange Commission, Battle of Saint-Fulgent, GLOBE, LLC, HBO Max, Complaint, Anti-Kickback Statute, Register, Court, Government, Form, Investment, Warner Bros., Company, Mergers and acquisitions, EPS, Remuneration, HBO, AT&T, Stark Law, Prospectus, WarnerMedia, Discovery

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points: 
  • NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • If you suffered a loss, you can request that the Court appoint you as lead plaintiff.

FLGT SHAREHOLDER NOTICE: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics (FLGT) Investors with Significant Losses to Contact Firm’s Attorneys Before Nov. Deadline in Securities Class Action

Retrieved on: 
Monday, October 31, 2022
DOJ, Fraud, SAN, Disclosure, Steve Berman (lawyer), Program, SEC, Genetics, GLOBE, NASDAQ, Stark Law, News, Person, Pharmaceutical industry, Tobacco, Battle of Saint-Fulgent

SAN FRANCISCO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now .
  • A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations.
  • Fulgent Genetics, Inc. (NASDAQ: FLGT) Securities Fraud Class Action:
    The litigation focuses on Fulgents previously claimed very strong and truly outstanding financial results.
  • If you invested in Fulgent and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – FLGT

Retrieved on: 
Sunday, October 30, 2022
Reward, NASDAQ, Court, COVID-19, District court, Anti-Kickback Statute, LLP, Genetics, SEC Rule 10b-5, Federal, Justice, Person, Remuneration, Securities Exchange Act of 1934, Office of Inspector General, U.S. Department of Health and Human Services, Company, Complaint, GLOBE, Physician, U.S. Securities and Exchange Commission, Stark Law, SEC, Pomerantz, Patient, Central District, News, U.S. Department of Justice Office of Legislative Affairs, Medicare, Genetic testing, Battle of Saint-Fulgent, Health, Ext, Disclosure, Pharmaceutical industry

NEW YORK, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and certain of its officers.

Key Points: 
  • NEW YORK, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and certain of its officers.
  • If you are a shareholder who purchased Fulgent securities during the Class Period, you have until November 21, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLGT

Retrieved on: 
Friday, October 28, 2022
Titan, Federal, LinkedIn, Advertising, NASDAQ, Class, Medicare, Stark Law, Remuneration, Facebook, THE, WHY, Battle of Saint-Fulgent, Health, I-Space (Chinese company), Court, GLOBE, TO, Twitter, Lists of schools in England, Genetics, Reward, Anti-Kickback Statute, Online gambling, Insurance, Tobacco, Pharmaceutical industry

NEW YORK, Oct. 28, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), of the important November 21, 2022 lead plaintiff deadline.

Key Points: 
  • WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

Retrieved on: 
Friday, October 28, 2022
SEC, Company, NASDAQ, Stark Law, Remuneration, GPM, Defendant, Anti-Kickback Statute, Securities Exchange Act of 1934, Court, News, GLOBE, Exchange, Justice, Lists of schools in England, Investment, Suite, Time, Stark, Privacy Office of the U.S. Department of Homeland Security, Genetics, U.S. Department of Justice Office of Legislative Affairs, Pharmaceutical industry, Battle of Saint-Fulgent

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Fulgent securities during the Class Period, you may move the Court no later than November 21, 2022 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

FULGENT DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Fulgent Genetics, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm

Retrieved on: 
Thursday, October 27, 2022
SEC, Stark Law, District court, Disclosure, NASDAQ, Medicare, Remuneration, Physician, Lead, Battle of Saint-Fulgent, Genetic testing, Anti-Kickback Statute, Patient, Health, News, GLOBE, COVID-19, Fraud, Insurance, Justice, Stark, Office of Inspector General, U.S. Department of Health and Human Services, Genetics, U.S. Department of Justice Office of Legislative Affairs, COPY, LLP, Reward, Central District, Private investigator, Pharmaceutical industry, Architecture

The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects.

Key Points: 
  • The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects.
  • As a result of Fulgents materially misleading statements and omissions to the public, Fulgent investors have suffered significant losses.
  • Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, October 27, 2022
PLTR, Mission statement, SEC, Company, Complaint, Federal, ADR, Prospectus, NASDAQ, Disclosure, Stark Law, Medicare, Growth, Remuneration, Government, IPO, ADS, Q2, ADR Institute of Alberta, War, Physician, Anti-Kickback Statute, Battle of Saint-Fulgent, Intelligence, Genetic testing, Annual report, Patient, Health, U.S. Securities and Exchange Commission, EPS, News, YSG, BCS, COVID-19, Federation, GLOBE, Justice, Lists of schools in England, Investment, NYSE, Stark, U.S. Department of Defense Strategy for Operating in Cyberspace, Sale, U.S. Department of Justice Office of Legislative Affairs, Reward, Security (finance), Animal, Pharmaceutical industry, Audit, Online gambling, P.C, Palantir Technologies, Barclays

The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.

Key Points: 
  • The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.
  • On May 9, 2022, Palantir issued a press release announcing its Q1 financial results and guidance for Q2.
  • For more information on the Barclays class action go to: https://bespc.com/cases/BCS
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.